Iowa SSB1169 ensures nonopioid drugs are not disadvantaged on Medicaid's preferred drug list and mandates health carriers to develop pain management.

Iowa SSB1169 amends the state's Medicaid program to ensure that nonopioid drugs approved by the FDA for pain management are not disadvantaged compared to opioid drugs on the preferred drug list. The bill requires that nonopioid drugs not be designated as nonpreferred if any opioid is designated as preferred. It also mandates that health carriers develop pain management access plans that cover at least two FDA-approved nonopioid prescription medications for pain and three nonpharmacologic treatment modalities.

Iowa SSB1169 ensures nonopioid drugs are not disadvantaged on Medicaid's preferred drug list and mandates health carriers to develop pain management.

Iowa SSB1169 amends the state's Medicaid program to ensure that nonopioid drugs approved by the FDA for pain management are not disadvantaged compared to opioid drugs on the preferred drug list. The bill requires that nonopioid drugs not be designated as nonpreferred if any opioid is designated as preferred. It also mandates that health carriers develop pain management access plans that cover at least two FDA-approved nonopioid prescription medications for pain and three nonpharmacologic treatment modalities.